FDA releases FY 2022 generic drug research summary
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsProject managementRegulatory Intelligence/PolicyResearch, Design and DevelopmentRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsProject managementRegulatory Intelligence/PolicyResearch, Design and Development